BUZZ-Protagonist Therapeutics surges after media reports J&J in talks to buy co
I'm PortAI, I can summarize articles.
Shares of Protagonist Therapeuticsrise 28.3% to an all-time high of $86Johnson & Johnsonis in discussions to buy PTGX, the Wall Street Journal reports, citing people familiar with the matterA deal is not guaranteed and the exact details being discussed could not be learned - WSJPTGX has a market value of $4.17 billion as of last close - LSEG dataUp to last close, stock up 71.4% YTD
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments